MGTA Annual Retained Earnings
-$402.03 M
-$76.46 M-23.49%
31 December 2022
Summary:
As of January 21, 2025, MGTA annual retained earnings is -$402.03 million, with the most recent change of -$76.46 million (-23.49%) on December 31, 2022. During the last 3 years, it has fallen by -$222.53 million (-123.98%).MGTA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Quarterly Retained Earnings
-$434.48 M
-$3.28 M-0.76%
30 June 2023
Summary:
As of January 21, 2025, MGTA quarterly retained earnings is -$434.48 million, with the most recent change of -$3.28 million (-0.76%) on June 30, 2023. Over the past year, it has dropped by -$68.69 million (-18.78%).MGTA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.5% | -18.8% |
| 3 y3 years | -124.0% | -98.8% |
| 5 y5 years | -789.2% | -520.4% |
MGTA Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | +4036.1% | +861.0% |
Magenta Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | -$434.48 M(+0.8%) |
| Mar 2023 | - | -$431.20 M(+7.3%) |
| Dec 2022 | -$402.03 M(+23.5%) | -$402.03 M(+5.3%) |
| Sept 2022 | - | -$381.85 M(+4.4%) |
| June 2022 | - | -$365.79 M(+5.0%) |
| Mar 2022 | - | -$348.52 M(+7.0%) |
| Dec 2021 | -$325.57 M(+28.0%) | -$325.57 M(+6.3%) |
| Sept 2021 | - | -$306.27 M(+6.0%) |
| June 2021 | - | -$288.85 M(+6.2%) |
| Mar 2021 | - | -$271.92 M(+6.9%) |
| Dec 2020 | -$254.43 M | -$254.43 M(+7.7%) |
| Sept 2020 | - | -$236.26 M(+8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | -$218.59 M(+9.6%) |
| Mar 2020 | - | -$199.51 M(+11.1%) |
| Dec 2019 | -$179.50 M(+74.7%) | -$179.50 M(+14.9%) |
| Sept 2019 | - | -$156.26 M(+15.5%) |
| June 2019 | - | -$135.27 M(+15.1%) |
| Mar 2019 | - | -$117.56 M(+14.4%) |
| Dec 2018 | -$102.73 M(+127.2%) | -$102.73 M(+19.4%) |
| Sept 2018 | - | -$86.05 M(+22.9%) |
| June 2018 | - | -$70.03 M(+24.2%) |
| Mar 2018 | - | -$56.37 M(+24.7%) |
| Dec 2017 | -$45.21 M(+365.1%) | -$45.21 M |
| Dec 2016 | -$9.72 M | - |
FAQ
- What is Magenta Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Magenta Therapeutics?
- What is Magenta Therapeutics annual retained earnings year-on-year change?
- What is Magenta Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Magenta Therapeutics?
- What is Magenta Therapeutics quarterly retained earnings year-on-year change?
What is Magenta Therapeutics annual retained earnings?
The current annual retained earnings of MGTA is -$402.03 M
What is the all time high annual retained earnings for Magenta Therapeutics?
Magenta Therapeutics all-time high annual retained earnings is -$9.72 M
What is Magenta Therapeutics annual retained earnings year-on-year change?
Over the past year, MGTA annual retained earnings has changed by -$76.46 M (-23.49%)
What is Magenta Therapeutics quarterly retained earnings?
The current quarterly retained earnings of MGTA is -$434.48 M
What is the all time high quarterly retained earnings for Magenta Therapeutics?
Magenta Therapeutics all-time high quarterly retained earnings is -$45.21 M
What is Magenta Therapeutics quarterly retained earnings year-on-year change?
Over the past year, MGTA quarterly retained earnings has changed by -$68.69 M (-18.78%)